Association of Plasma Calprotectin Levels with Disease Severity in COVID-19 Patients
Objectives Inflammation plays an important role in the pathogenesis of COVID-19. Calprotectin, a protein released by inflammatory cells, is associated with this inflammatory response. Materials and Methods A prospective study was conducted on 30 patients with mild to moderate COVID-19, 30 patients with severe COVID-19, and 30 healthy controls. Calprotectin levels were analyzed with a commercially purchased Cloud Cloning Kit. Results Plasma calprotectin levels in COVID-19 patients (12.5 +/- 8.8 ng/mL) were significantly greater than those in the controls (8.23 +/- 2.99 ng/mL; p = 0.012). The calprotectin level in the mild to moderate COVID-19 group (9.85 +/- 6.94 ng/mL) was significantly lower than that in the severe COVID-19 group (15.19 +/- 9.87 ng/mL; p = 0.019). The recommended cutoff value for the calprotectin level was 7.45 ng/mL with 63.3% sensitivity and 53.3% specificity. Seventeen (28.3%) of the COVID-19 patients died due to COVID-19-related causes. The calprotectin level in the exiting patients (16.33 +/- 7.65 ng/mL) was significantly greater than the calprotectin level in the living cases (11.01 +/- 8.95 ng/mL; p = 0.035). Conclusion Calprotectin levels were greater in COVID-19 patients than in healthy controls and in more severe patients than in mild to moderate cases. Calprotectin levels may be used as a biomarker to predict severe COVID-19 cases.
- Dergi
- IBNOSINA JOURNAL OF MEDICINE AND BIOMEDICAL SCIENCES
- Yıl
- 2025
- Cilt
- 17
- Sayı
- 02
- Sayfa
- 61-67
- ISSN
- 1947-489X
- DOI
- 10.1055/s-0045-1808245
- WoS UID
- WOS:001483985100001